[Skip to Content]
[Skip to Content Landing]
Views 557
Citations 0
Correction
March 7, 2019

Incomplete Conflict of Interest Disclosures

JAMA Oncol. 2019;5(4):579. doi:10.1001/jamaoncol.2019.0286

In 11 articles published in JAMA Oncology in 2016 through 2018,1-11 one of the authors, Charles S. Fuchs, MD, MPH, had omissions in his disclosures of potential conflicts of interest. A letter to the editor12 explains these omissions in detail. These 11 articles have been corrected online.

References
1.
Cao  Y, Nishihara  R, Wu  K,  et al.  Population-wide impact of long-term use of aspirin and the risk for cancer.  JAMA Oncol. 2016;2(6):762-769. doi:10.1001/jamaoncol.2015.6396PubMedGoogle ScholarCrossref
2.
Song  M, Nishihara  R, Cao  Y,  et al.  Marine ω-3 polyunsaturated fatty acid intake and risk of colorectal cancer characterized by tumor-infiltrating T cells.  JAMA Oncol. 2016;2(9):1197-1206. doi:10.1001/jamaoncol.2016.0605PubMedGoogle ScholarCrossref
3.
Keum  N, Bao  Y, Smith-Warner  SA,  et al.  Association of physical activity by type and intensity with digestive system cancer risk.  JAMA Oncol. 2016;2(9):1146-1153. doi:10.1001/jamaoncol.2016.0740PubMedGoogle ScholarCrossref
4.
Mehta  RS, Nishihara  R, Cao  Y,  et al.  Association of dietary patterns with risk of colorectal cancer subtypes classified by Fusobacterium nucleatum in tumor tissue.  JAMA Oncol. 2017;3(7):921-927. doi:10.1001/jamaoncol.2016.6374PubMedGoogle ScholarCrossref
5.
Qian  ZR, Rubinson  DA, Nowak  JA,  et al.  Association of alterations in main driver genes with outcomes of patients with resected pancreatic ductal adenocarcinoma.  JAMA Oncol. 2018;4(3):e173420. doi:10.1001/jamaoncol.2017.3420PubMedGoogle ScholarCrossref
6.
Song  M, Wu  K, Meyerhardt  JA,  et al.  Fiber intake and survival after colorectal cancer diagnosis.  JAMA Oncol. 2018;4(1):71-79. doi:10.1001/jamaoncol.2017.3684PubMedGoogle ScholarCrossref
7.
Tabung  FK, Liu  L, Wang  W,  et al.  Association of dietary inflammatory potential with colorectal cancer risk in men and women.  JAMA Oncol. 2018;4(3):366-373. doi:10.1001/jamaoncol.2017.4844PubMedGoogle ScholarCrossref
8.
Fuchs  CS, Doi  T, Jang  RW,  et al.  Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE-059 trial.  JAMA Oncol. 2018;4(5):e180013. doi:10.1001/jamaoncol.2018.0013PubMedGoogle ScholarCrossref
9.
Van Blarigan  EL, Fuchs  CS, Niedzwiecki  D,  et al.  Association of survival with adherence to the american cancer society nutrition and physical activity guidelines for cancer survivors after colon cancer diagnosis: the CALGB 89803/Alliance trial.  JAMA Oncol. 2018;4(6):783-790. doi:10.1001/jamaoncol.2018.0126PubMedGoogle ScholarCrossref
10.
Simon  TG, Ma  Y, Ludvigsson  JF,  et al.  Association between aspirin use and risk of hepatocellular carcinoma.  JAMA Oncol. 2018;4(12):1683-1690. doi:10.1001/jamaoncol.2018.4154PubMedGoogle ScholarCrossref
11.
Liu  PH, Wu  K, Ng  K,  et al.  Association of obesity with risk of early-onset colorectal cancer among women.  JAMA Oncol. 2018;5(1):37-44. doi:10.1001/jamaoncol.2018.4280PubMedGoogle ScholarCrossref
12.
Fuchs  CS.  Omitted disclosures of potential conflicts of interest in articles published in JAMA Oncology  [published online March 7, 2019].  JAMA Oncol. doi:10.1001/jamaoncol.2019.0235Google Scholar
×